MedTrace Logo

Psychostimulant Abuse - Novel Treatment Approaches - 1

NCT00000325 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2017-01-12

No results posted yet for this study

Summary

To determine if acute assessments of profasi and factrel affect plasma cocaine levels and cocaine-induced behavioral changes in men.

Conditions

  • Cocaine-Related Disorders

Interventions

BEHAVIORAL

Gonadorelin

Sponsors & Collaborators

  • Mclean Hospital

    collaborator OTHER

  • National Institute on Drug Abuse (NIDA)

    lead NIH

Principal Investigators

  • Jack Mendelson, M.D. · Mclean Hospital

Study Design

Purpose
TREATMENT

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Completion
2001-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000325 on ClinicalTrials.gov